Vir Biotechnology Inc. (VIR)
NASDAQ: VIR
· Real-Time Price · USD
4.51
0.07 (1.58%)
At close: Aug 15, 2025, 3:59 PM
4.49
-0.43%
After-hours: Aug 15, 2025, 07:24 PM EDT
Vir Biotechnology Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 299.32M | 273.57M | 222.95M | 168.35M | 310.81M | 174.05M | 254.84M | 452.1M | 666.95M | 824.91M | 848.63M | 963.74M | 1.51B | 812.36M | 347.81M | 714.52M | 741.95M | 521.4M |
Short-Term Investments | 387.64M | 528.09M | 682.4M | 746.12M | 854.2M | 989.05M | 1.28B | 1.24B | 1.18B | 1.43B | 1.55B | 1.38B | 690.52M | 447.72M | 360.33M | 224.93M | 84.11M | 211.64M |
Long-Term Investments | 286.1M | 218.14M | 190.01M | 277.88M | 286.36M | 366.15M | 111.72M | 39.62M | 52.36M | 49.19M | 23.93M | 34.1M | 97.58M | 103.53M | 201.39M | 7M | 50.68M | 12.7M |
Other Long-Term Assets | 20.14M | 12.13M | 18.42M | 11.56M | 13.29M | 12.49M | 12.38M | 21.78M | 23.6M | 23.29M | -228.5M | 13.48M | 11.17M | 12.04M | -87.07M | 2.34M | 14.89M | 1.4M |
Receivables | n/a | n/a | n/a | n/a | 7.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7M | 1.22B | 773.08M | 93M | n/a | 225M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.39M | 163K | -6.94M | n/a | n/a | n/a | n/a | 8.59M | 6.11M | 6.4M | 8.6M |
Other Current Assets | 48.74M | 130.54M | 137.11M | 48.6M | 45.1M | 17.43M | 62.4M | 20.89M | 26.16M | 28.86M | 59.2M | 15.76M | 14.95M | 14.4M | 8.59M | 6.11M | 7.6M | 9.3M |
Total Current Assets | 735.71M | 932.21M | 1.04B | 1.05B | 1.21B | 1.21B | 1.59B | 1.77B | 1.95B | 2.36B | 2.52B | 2.41B | 2.29B | 2.57B | 1.56B | 1.07B | 862.29M | 993.11M |
Property-Plant & Equipment | 125.65M | 120.24M | 122.86M | 125.57M | 128.33M | 162.82M | 167.2M | 171.93M | 179.06M | 185.26M | 188.17M | 184.94M | 172.01M | 153.91M | 130.05M | 84.18M | 79.22M | 77.75M |
Goodwill & Intangibles | 24.93M | 25.01M | 25.04M | 36.2M | 35.84M | 39.4M | 39.53M | 42.39M | 42.53M | 49.56M | 49.69M | 49.83M | 49.96M | 50.09M | 50.22M | 50.36M | 50.49M | 50.62M |
Total Long-Term Assets | 456.83M | 375.52M | 356.33M | 451.2M | 463.81M | 580.87M | 371.86M | 275.72M | 297.54M | 307.3M | 283.01M | 282.35M | 330.73M | 319.58M | 391.45M | 143.88M | 195.29M | 142.47M |
Total Assets | 1.19B | 1.31B | 1.4B | 1.5B | 1.67B | 1.79B | 1.96B | 2.04B | 2.24B | 2.67B | 2.8B | 2.7B | 2.62B | 2.89B | 1.95B | 1.21B | 1.06B | 1.14B |
Account Payables | 12.23M | 3.73M | 5.08M | 7.3M | 4.39M | 7.11M | 6.33M | 3.63M | 12.36M | 12.15M | 6.42M | 2.72M | 10.62M | 10.96M | 6.52M | 4.22M | 11.03M | 3.7M |
Deferred Revenue | 10.11M | 11.94M | 12.65M | 15.2M | 16.7M | 14.69M | 64.85M | 15.31M | 15.68M | 17.22M | 15.52M | 22.86M | 113.16M | 113.74M | 98.21M | 96.15M | 44.72M | 262.93M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 82.66M | 17.5M | 16.06M | 43.88M | 7.6M | 7.6M | 9.2M | 9.22M | 7.61M | 7.61M | 7.65M | 98.19M | 3.04M | 3.04M | 96.83M | 114.66M | 76.4M | 85.17M |
Total Current Liabilities | 105M | 137.29M | 119.66M | 117.16M | 96.41M | 94.07M | 175.41M | 165.05M | 225.62M | 485.29M | 511.03M | 308.2M | 477.87M | 702.36M | 341.24M | 233.72M | 146.02M | 361.1M |
Long-Term Debt | 93.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 46.65M | 38.45M | 38.63M | 47.06M | 44.45M | 41.85M | 40.22M | 37.43M | 37.02M | 31.93M | 32.8M | 37.88M | 36.05M | 26.64M | 25.36M | 24.54M | 46.55M | 49.85M |
Total Long-Term Liabilities | 140.06M | 126.62M | 128.77M | 140.47M | 139.47M | 152.54M | 194.45M | 204.76M | 208.04M | 209.85M | 213.1M | 237.91M | 189.11M | 183.75M | 181.18M | 100.22M | 174.23M | 123.53M |
Total Liabilities | 245.06M | 263.91M | 248.43M | 257.63M | 235.88M | 246.61M | 369.85M | 369.81M | 433.67M | 695.13M | 724.13M | 546.12M | 666.98M | 886.12M | 522.42M | 333.94M | 320.26M | 484.63M |
Total Debt | 93.41M | 96.09M | 97.89M | 112.81M | 114.51M | 121.08M | 124.54M | 114.12M | 117.81M | 121.46M | 127.97M | 131.06M | 134.31M | 136.88M | 133.56M | 72.16M | 72.46M | 70.18M |
Common Stock | 14K | 14K | 14K | 14K | 14K | 14K | 13K | 13K | 13K | 13K | 13K | 13K | 13K | 13K | 13K | 13K | 13K | 13K |
Retained Earnings | -991.71M | -880.75M | -759.78M | -655.2M | -441.48M | -303.1M | -237.82M | -121.85M | 41.56M | 236.34M | 377.24M | 478.84M | 303.53M | 380.02M | -138.6M | -663.85M | -774.28M | -836.1M |
Comprehensive Income | -2.22M | -1.98M | -1.72M | 1.13M | -2.88M | -2.4M | -815K | -1.9M | -2.9M | -3.22M | -9.12M | -11.88M | -7.55M | -4.8M | -1.1M | -1.31M | -1.33M | -1.3M |
Shareholders Equity | 947.47M | 1.04B | 1.15B | 1.24B | 1.43B | 1.55B | 1.59B | 1.68B | 1.81B | 1.97B | 2.08B | 2.15B | 1.95B | 2B | 1.43B | 876.27M | 737.33M | 650.95M |
Total Investments | 673.74M | 746.23M | 872.42M | 1.02B | 1.14B | 1.36B | 1.39B | 1.27B | 1.22B | 1.46B | 1.55B | 1.42B | 788.11M | 551.25M | 561.72M | 224.93M | 134.79M | 211.64M |